NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Jiangsu Vcare Pharmatech Co., Ltd.

Jiangsu Vcare Pharmatech Co., Ltd.

Private
NanjingHealthcare & Life Scienceshttps://www.vcarepharmatech.com

Last Round

Series C

Extension

Jun 2, 2026

Total Funding Raised

$224.8M

Company Overview

Jiangsu Vcare Pharmatech Co., Ltd. is a biopharmaceutical company that focuses on innovative drug research and development and provides comprehensive pharmaceutical industry chain services including CRO and CDMO.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Clinical Trials, Pharma Supply Chain, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

CRDMO servicesinnovative drug developmentcontract research organizationCROcontract development and manufacturingCDMOAPI manufacturingsmall molecule therapeuticspharma servicesdrug pipelineprocess developmentcustom synthesiscardiovascular drugsoncology drugsautoimmune disease treatmentanti-thrombotic agentCMC supportdrug licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Jiangsu Vcare Pharmatech Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

Jiangsu Vcare Pharmatech Co., Ltd. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Jiangsu Vcare Pharmatech Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series C ExtensionJun 2, 2026
Series C ExtensionJan 22, 2025
Series CJan 2, 2024
Series BDec 26, 2022
Series AMay 6, 2022
Series A
Jul 29, 2021

Jiangsu Vcare Pharmatech Co., Ltd. Investors

Notable investors and investment history

Jiangsu Vcare Pharmatech Co., Ltd. investors
InvestorRounds
Hongcheng CapitalSeries B
DYEE CapitalSeries C
SDIC Capital Co., Ltd.Series C Extension, Series B, Series A
南京市创新投资集团有限责任公司Series C, Series A
China Life Private Equity InvestmentSeries C
Yangtze River Industry GroupSeries A, Series B
China Life Private Equity Investment Co., Ltd.Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 26, 2022

    $29M round with participation from SDIC Capital and Hongcheng Capital.

Jiangsu Vcare Pharmatech Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Jiangsu Vcare Pharmatech Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Jiangsu Vcare Pharmatech Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersNanjing
Employee Range8
Year Founded2010
Last FundingJun 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.